Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Simi Valley › NPI 1063495190
Hospital

Simi Valley Hospital and Health Care Services

Simi Valley Hospital and Health Care Services was paid $19.94M by Medicaid between Jan 2018 and Nov 2024, across 190 billing codes. Its largest line is 0450, Emergency room services — 9.3% of everything it billed.

33Billing provider infoSIMI VALLEY HOSPITAL AND HEALTH CARE SERVICES
SIMI VALLEY, CA 93065
33aNPI1063495190assigned 11/22/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$19.94M
24GClaims595,394
24DCodes billed190
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#122 of 410
Median peer was paid$6.90M
This provider vs. median2.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201877,876$1.69M
201983,168$1.82M
202071,031$1.75M
202177,474$2.57M
2022108,877$4.14M
2023110,733$5.14M
2024incomplete66,235$2.84M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 9.3% 38,852 33,948 $1.86M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 7.5% 31,106 27,259 $1.50M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5.0% 14,821 13,290 $1.00M
99281 Emergency department visit for the evaluation and management, self-limited or minor 4.7% 1,602 953 $944K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 3.9% 10,497 10,082 $774K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 3.6% 3,941 3,657 $723K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.5% 3,180 3,104 $700K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3.0% 6,966 6,646 $592K
96375 Therapeutic injection; each additional sequential IV push 2.7% 11,470 10,132 $541K
97530 Therapeutic activities, direct patient contact, each 15 minutes 2.6% 4,441 1,607 $522K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 2.5% 3,440 3,171 $507K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.4% 8,178 7,852 $471K
178 more codes
99285 Emergency room visit (most serious) 2.3% 2,438 $468K
70450 Computed tomography, head or brain; without contrast material 2.3% 5,522 $467K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2.2% 2,174 $441K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.2% 3,798 $432K
77067 Screening mammography, bilateral, including computer-aided detection 2.1% 4,100 $410K
0360 2.0% 3,558 $389K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.8% 16,732 $354K
80053 Comprehensive metabolic panel 1.8% 33,554 $351K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.6% 4,704 $320K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.5% 6,817 $294K
96361 Intravenous infusion, hydration; each additional hour 1.4% 9,351 $283K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.4% 2,570 $276K
A4649 Surgical supply; miscellaneous 1.3% 30,719 $269K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.3% 4,565 $267K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.1% 3,109 $225K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.1% 2,780 $220K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.1% 35,530 $210K
J3490 Unclassified drugs <1% 9,616 $185K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 10,031 $179K
71275 Computed tomographic angiography, chest, with contrast material <1% 763 $151K
71045 Radiologic examination, chest; single view <1% 12,805 $147K
72125 Computed tomography, cervical spine; without contrast material <1% 1,151 $144K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 4,481 $140K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,817 $137K
0160 <1% 1,582 $136K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,197 $119K
93971 <1% 1,394 $111K
83880 <1% 5,593 $107K
84484 <1% 12,917 $96K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,836 $82K
83690 <1% 13,422 $79K
76830 Ultrasound, transvaginal <1% 1,448 $75K
81001 <1% 21,796 $71K
71046 Radiologic examination, chest; 2 views <1% 3,441 $68K
77066 Tomosynthesis, mammo <1% 699 $68K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,701 $64K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,568 $64K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,330 $63K
87040 <1% 7,433 $63K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,688 $62K
J2270 Injection, morphine sulfate, up to 10 mg <1% 6,785 $58K
J7030 Infusion, normal saline solution , 1000 cc <1% 8,939 $58K
93970 <1% 397 $56K
76801 <1% 836 $53K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,194 $51K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,320 $50K
Z7502 <1% 1,320 $49K
J7120 Ringers lactate infusion, up to 1000 cc <1% 4,414 $48K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,042 $43K
J2704 Injection, propofol, 10 mg <1% 2,784 $42K
83605 <1% 5,389 $42K
99070 <1% 610 $41K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 1,380 $39K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,429 $37K
76642 <1% 739 $37K
77065 Tomosynthesis, mammo <1% 436 $35K
80143 <1% 1,460 $34K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 4,698 $33K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 652 $31K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 429 $30K
72100 <1% 1,094 $28K
80179 <1% 1,445 $27K
73630 <1% 1,209 $27K
73562 <1% 1,247 $25K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,681 $25K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 505 $24K
87081 <1% 4,338 $24K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 740 $23K
73610 <1% 973 $22K
73030 <1% 867 $20K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,518 $20K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 595 $19K
83735 <1% 5,599 $18K
81025 <1% 4,513 $18K
84703 <1% 3,377 $17K
74018 <1% 851 $17K
80048 Basic metabolic panel (calcium, ionized) <1% 2,354 $17K
85379 <1% 2,093 $16K
87186 <1% 2,315 $16K
90715 <1% 479 $16K
73130 <1% 786 $16K
85610 <1% 5,808 $16K
88342 <1% 1,414 $16K
87400 <1% 1,975 $16K
84443 Thyroid stimulating hormone (TSH) <1% 1,668 $16K
J2060 Injection, lorazepam, 2 mg <1% 2,722 $14K
82550 <1% 2,964 $14K
87077 <1% 1,974 $14K
99199 Unlisted special service, procedure or report <1% 291 $13K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 56 $13K
S0164 Injection, pantoprazole sodium, 40 mg <1% 675 $13K
0250 <1% 2,832 $12K
84145 <1% 466 $11K
70551 Magnetic resonance imaging, brain; without contrast material <1% 77 $10K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 479 $10K
73110 <1% 431 $10K
82962 <1% 1,685 $9K
85730 <1% 2,389 $9K
J1650 Injection, enoxaparin sodium, 10 mg <1% 96 $8K
88313 <1% 932 $8K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,581 $8K
86140 <1% 1,444 $7K
84702 <1% 645 $7K
29125 <1% 409 $7K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,479 $7K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 365 $6K
87807 <1% 926 $6K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,024 $6K
85027 <1% 1,238 $6K
87088 <1% 1,034 $6K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 309 $5K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 39 $5K
86901 <1% 1,310 $5K
0710 <1% 262 $5K
82948 <1% 2,204 $5K
70496 <1% 26 $5K
99203 Doctor's office visit, new patient (routine) <1% 180 $5K
70486 <1% 52 $5K
76641 <1% 51 $5K
70498 <1% 26 $5K
77080 <1% 150 $4K
93041 <1% 245 $4K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 453 $4K
0259 <1% 931 $4K
71250 <1% 43 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 43 $3K
84100 <1% 2,635 $3K
85007 <1% 1,171 $3K
99214 Doctor's office visit, returning patient (more involved) <1% 36 $3K
J3475 Injection, magnesium sulfate, per 500 mg <1% 80 $3K
72131 <1% 25 $2K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 15 $2K
0270 <1% 1,566 $2K
85652 <1% 840 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 312 $2K
12001 <1% 77 $2K
80061 Lipid panel <1% 655 $2K
86900 <1% 631 $1K
76770 <1% 41 $1K
72040 <1% 83 $1K
93017 <1% 29 $1K
29515 <1% 110 $1K
G0378 Hospital observation service, per hour <1% 29 $1K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 345 $1K
J2550 Injection, promethazine hcl, up to 50 mg <1% 190 $1K
J1815 Injection, insulin, per 5 units <1% 343 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 27 $1K
87070 <1% 196 $1K
94060 <1% 41 $1K
73140 <1% 94 $999.81
76775 <1% 38 $984.13
36415 Collection of venous blood by venipuncture <1% 810 $766.52
73080 <1% 40 $717.31
83874 <1% 137 $711.23
Z7610 <1% 64 $679.08
86769 <1% 25 $674.08
94729 <1% 12 $497.40
82150 <1% 136 $487.95
94726 <1% 12 $455.88
80076 <1% 59 $364.51
12011 <1% 14 $339.00
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 60 $329.34
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 27 $300.00
0636 <1% 70 $280.95
73502 <1% 12 $265.07
83036 Hemoglobin; glycosylated (A1C) <1% 76 $206.91
86308 <1% 41 $194.85
94664 <1% 14 $179.60
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 384 $152.76
87205 <1% 75 $141.27
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 28 $137.08
81003 <1% 93 $134.04
86850 <1% 67 $132.43
94760 <1% 15 $72.67
J0690 Injection, cefazolin sodium, 500 mg <1% 15 $69.42
84439 <1% 13 $44.31
J1644 Injection, heparin sodium, per 1000 units <1% 13 $41.76
87641 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJOBE, MEREDITH (TREASURER)
Parent organizationADVENTIST HEALTH SYSTEM/WEST
Same official

Other billing entities under JOBE, MEREDITH

Full network →
ProviderLocationPaid
Adventist Health DelanoDelano, CA$35.28M
Adventist Health DelanoDelano, CA$22.39M
Adventist Health DelanoWasco, CA$5.38M
Adventist Health DelanoDelano, CA$169K
Adventist Health DelanoDelano, CA$118K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.